Comparing leukocyte‐ and thrombocyte‐rich fibrin and autologous grafts for the treatment of experimentally induced wounds in the tarsometatarsus of chickens
Veterinary Record · 2026
DOI: 10.1002/vetr.70220 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Veterinary Record, 2026. Verfasst von Vivian Ferreira Rech und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Surgery and Animal Reproduction, School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botuc…. Hauptthemen laut MEDLINE: Chickens, Platelet-Rich Fibrin, Wound Healing, Leukocytes. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: by Capes (Coordination for the Improvement of Higher Education Personnel), and CNPq (National Council for Scientific and Technological Development).
Abstract (Originalsprache)
Background
Managing open wounds in birds is challenging. This study compared leukocyte‐ and thrombocyte‐rich fibrin (L‐TRF) and autologous grafts for treating wounds in the tarsometatarsus of chickens.
Methods
Full‐thickness wounds were experimentally induced in the tarsometatarsus of 23 healthy adult chickens. The wounds were then treated with either a bandage dressing (G1, n = 7), an L‐TRF membrane (G2, n = 8) or an autologous skin graft (G3, n = 8). Wounds were assessed on days 7, 14, 21 and 28. In G2, L‐TRF membranes were reapplied at each time point.
Results
By day 28, 71.4% of wounds in G1 remained unhealed, while 87.5% in G2 were fully healed. Wound reduction was significantly greater in G2 than G1 at all times, especially on days 14 and 21. No difference in wound area was observed on day 7, but wounds in G2 were smaller than in G1 on days 14, 21 and 28. By day 28, 75% of G3 grafts survived, while 25% showed necrosis. Histology showed higher angiogenesis and collagen production in G2 than G3, with more inflammation in G3. Re‐epithelialisation was higher in G2 than in G1.
Limitations
Wound healing in the tarsometatarsus resulted in tissue differing from the original, regardless of the treatment applied.
Conclusions
The L‐TRF membrane was the most effective treatment for skin wounds induced in the tarsometatarsus of chickens, outperforming autologous skin grafts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Surgery and Animal Reproduction, School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botucatu, Brazil.
- Veterinary Pathology Laboratory, Department of Pathology, Federal University of Santa Maria (UFSM), Santa Maria, Brazil.
ORCID-Profile: Vivian Ferreira Rech, Sheila Canevese Rahal, Renata Dalcol Mazaro, Luna Scarpari Rolim, Guilherme Rech Cassanego, Matheus Yuri Dos Santos, Rafael Almeida Fighera
Förderung
- by Capes (Coordination for the Improvement of Higher Education Personnel)
- and CNPq (National Council for Scientific and Technological Development)
Zitieren
APA
Rech, V. F., Rahal, S. C., Mazaro, R. D., Rolim, L. S., Cassanego, G. R., Dos Santos, M. Y., & Fighera, R. A. (2026). Comparing leukocyte‐ and thrombocyte‐rich fibrin and autologous grafts for the treatment of experimentally induced wounds in the tarsometatarsus of chickens. Veterinary Record. https://doi.org/10.1002/vetr.70220
Vancouver
Rech VF, Rahal SC, Mazaro RD, Rolim LS, Cassanego GR, Dos Santos MY, et al. Comparing leukocyte‐ and thrombocyte‐rich fibrin and autologous grafts for the treatment of experimentally induced wounds in the tarsometatarsus of chickens. Veterinary Record. 2026. doi:10.1002/vetr.70220
BibTeX
@article{Rech2026,
author = {Rech, Vivian Ferreira and Rahal, Sheila Canevese and Mazaro, Renata Dalcol and Rolim, Luna Scarpari and Cassanego, Guilherme Rech and Dos Santos, Matheus Yuri and Fighera, Rafael Almeida},
title = {Comparing leukocyte‐ and thrombocyte‐rich fibrin and autologous grafts for the treatment of experimentally induced wounds in the tarsometatarsus of chickens},
journal = {Veterinary Record},
year = {2026},
doi = {10.1002/vetr.70220}
}
EUVIMED